Phosphatidylserine enriched with polyunsaturated n ‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial
Epilepsia Open · 2024-04 · 9 (2) · 582-591
DOI: 10.1002/epi4.12892 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia Open, online erschienen am 25.01.2024. Verfasst von Sylvain Rheims und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Neurology and Epileptology, Hospices Civils de Lyon and Lyon 1 University, Lyon, France. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Fatty Acids, Omega-3, Epilepsy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French Ministery of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Attention‐deficit hyperactivity disorder (ADHD) is a frequent comorbidity in children with epilepsy, which management mostly relies on the usual treatments of ADHD, especially methylphenidate. Supplementation with polyunsaturated n ‐3 Fatty Acid (PUFA) has been proposed as an alternative therapeutic approach in ADHD without epilepsy but has never been evaluated in epilepsy‐associated ADHD.
Methods
A multicenter double blind randomized placebo‐controlled trial evaluating supplementation with PUFA, in eicosapentaenoic‐ and docosahexaenoic‐acid form, conjugated to a phospholipid vector (PS‐Omega3) in children aged >6 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Neurology and Epileptology, Hospices Civils de Lyon and Lyon 1 University, Lyon, France.
- Lyon Neuroscience Research Center, INSERM U1028/CNRS UMR 5292, Lyon 1 University, Lyon, France.
- Epilepsy Institute, Lyon, France.
- Epilepsy, Sleep and Paediatric Neurophysiology Department, Hospices Civils de Lyon, Lyon, France.
- Clinical Investigation Centre 1407, Hospices Civils de Lyon-Inserm, Hôpital Louis Pradel, Bron, France.
- Department of Biostatistics, Hospices Civils de Lyon, Lyon, France.
ORCID-Profile: Sylvain Rheims, Frédéric Villéga, Anne de Saint-Martin, Stéphane Auvin, Mathieu Milh, Alexis Arzimanoglou, Laurent Bezin
Förderung
- French Ministery of Health
Zitieren
APA
Rheims, S., Herbillon, V., Gaillard, S., Mercier, C., Villeuve, N., Villéga, F., Cances, C., Castelnau, P., Napuri, S., de Saint-Martin, A., Auvin, S., Nguyen The Tich, S., Berquin, P., de Bellecize, J., Milh, M., Roy, P., Arzimanoglou, A., Bodennec, J., Bezin, L., …, & investigators of the AGPI study group (2024). Phosphatidylserine enriched with polyunsaturated n ‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial. Epilepsia Open, 9(2), 582-591. https://doi.org/10.1002/epi4.12892
Vancouver
Rheims S, Herbillon V, Gaillard S, Mercier C, Villeuve N, Villéga F, et al. Phosphatidylserine enriched with polyunsaturated n ‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial. Epilepsia Open. 2024;9(2):582-591. doi:10.1002/epi4.12892
BibTeX
@article{Rheims2024,
author = {Rheims, Sylvain and Herbillon, Vania and Gaillard, Ségolène and Mercier, Catherine and Villeuve, Nathalie and Villéga, Frédéric and Cances, Claude and Castelnau, Pierre and Napuri, Silvia and de Saint-Martin, Anne and Auvin, Stéphane and Nguyen The Tich, Sylvie and Berquin, Patrick and de Bellecize, Julitta and Milh, Mathieu and Roy, Pascal and Arzimanoglou, Alexis and Bodennec, Jacques and Bezin, Laurent and Kassai, Behrouz and investigators of the AGPI study group, investigators of the AGPI study group},
title = {Phosphatidylserine enriched with polyunsaturated n ‐3 fatty acid supplementation for attention‐deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo‐controlled trial},
journal = {Epilepsia Open},
year = {2024},
volume = {9},
number = {2},
pages = {582--591},
doi = {10.1002/epi4.12892}
}
EUVIMED